Replies to post #252855 on Innovation Pharmaceuticals Inc (IPIX)

[frrol]

That's pretty clear. Combo treatment is often concurrent, and this is not the case, I was mistaken. I do recall reading that Kevetrin's theorized transcription-dependent MOA would potentiate radiation and chemotherapies, meaning that it would be Kevetrin first, then the other treatment(s). (This has nothing to do with allowing a patient to resume SOC, that is just the humane thing to do.)